Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens
Transfusion · 2024
DOI: 10.1111/trf.17609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Kelsey Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Thrombocytopenia, Antigens, Human Platelet. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Predicting whether a patient's platelet refractoriness (PR) is due to immune or nonimmune causes can be challenging. This study compared the demographics and clinical history of PR patients with human leukocyte antigen (HLA) antibodies (HLA‐PR) versus PR patients without HLA antibodies. Materials and Methods A retrospective review of all patients with PR consults at a single institution over a 3‐year period was performed. Patient charts were reviewed for all patients with confirmed PR, and demographic information (e.g., sex, race and ethnicity, preferred language) and clinical history (e.g., pregnancy, transfusion, primary diagnosis) were collected. Patient characteristics were compared among the HLA and non‐HLA cohorts.
Results
A total of 295 patients with confirmed PR were identified, of whom approximately 70% did not have HLA antibodies and 30% did. Approximately 84% of the HLA‐PR cohort was female. A history of transfusions was not associated with HLA‐PR ( p = .1). A history of pregnancy was strongly associated with the occurrence of HLA‐PR ( p < .001). Splenomegaly was associated with PR in the absence of HLA alloimmunization whereas infection, fever, bleeding, and disseminated intravascular coagulation were not.
Conclusion
In this single‐institution retrospective review, a history of pregnancy was strongly associated with HLA‐PR, whereas a history of transfusion was not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Pathology, University of California San Diego, San Diego, California, USA.
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Laura Stephens, Elena Nedelcu, Sara Bakhtary
Förderung
- NCATS NIH HHS
- NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Liu, K., Stephens, L., Nedelcu, E., & Bakhtary, S. (2024). Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens. Transfusion. https://doi.org/10.1111/trf.17609
Vancouver
Liu K, Stephens L, Nedelcu E, Bakhtary S. Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens. Transfusion. 2024. doi:10.1111/trf.17609
BibTeX
@article{Liu2024,
author = {Liu, Kelsey and Stephens, Laura and Nedelcu, Elena and Bakhtary, Sara},
title = {Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17609}
}
EUVIMED